InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,880.36
(
-1.16%
)
US TECH 100
19,923.60
(
-2.08%
)
Dow Jones
43,487.01
(
-0.60%
)
Brent Oil
72.11
(
-0.15%
)
Bitcoin
89,147.23
(
2.06%
)
Post# of 253614
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: north40000 post# 78944

Wednesday, 06/03/2009 4:13:23 PM

Wednesday, June 03, 2009 4:13:23 PM

Post# of 253614
The recent downdraft in share price of GILD was partly due to worries regarding cv events in darusentan's phase III DAR 311 trial in resistant hypertension. In the HIV arena, which they dominate, GILD is after a quad combo - to include elvitegravir in a single pill with Truvada and GS-9350, this will be a big commercial advantage over potential competition.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up